37481-62-2

Upstream product

• 951-82-6 3,4,5-trimethoxyphenyl acetic acid 
• 55536-65-7 3,4-di(benzyloxy)phenethylamine 

Downstream Products

• 55536-67-9 1-(3',4',5'-Trimethoxybenzyl)-6,7-dibenzyloxy-3,4-dihydroisoquinolin 
• 55536-68-0 1-(3,4,5-Trimethoxybenzoyl)-6,7-dibenzyloxy-3,4-dihydroisochinolin 
• 74444-93-2 2-Benzyl-1-(3,4,5-trimethoxybenzoyl)-6,7-dibenzyloxy-3,4-dihydroxy-isochinoliniumbromid 
• 74444-94-3 (+/-) 3-Benzyl-2-(3,4,5-trimethoxyphenyl)-7,8-dibenzyloxy-2,3,4,5-tetrahydro-1H-3-benzazepin. HCl 
• 74444-95-4 (+/-) 2-(3,4,5-Trimethoxyphenyl)-7,8-dihydroxy-2,3,4,5-tetrahydro-1H-3-benzazepin. HCl 
• 102920-98-9 1-(3,4,5-trimethoxybenzyl)-2-(β-hydroxyethyl)-6,7-bis(benzyloxy)-1,2,3,4-tetrahydroisoquinoline 
• 102921-08-4 1-(3,4,5-trimethoxybenzyl)-6,7-bis(benzyloxy)-1,2,3,4-tetrahydroisoquinoline 

Relevant academic research and scientific papers

Syntheses and β-adrenergic agonist and antiaggregatory properties of N-substituted trimetoquinol analogues

Trimetoquinol [1-(3,4,5-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, TMQ] is a potent β-adrenergic receptor agonist and inhibitor of human platelet aggregation. Selective cleavage of O-benzyl groups in the presence of an N-benzyl group